Last reviewed · How we verify
Quality of Life in Patients With Allergic Rhinitis: a Clinical Trial Comparing the Use of Bilastine Versus Loratadine (QolRhinitis)
The purpose of this study was to verify whether there were differences in health-related quality of life of patients with allergic rhinitis treated with bilastine 20 mg compared to those treated with loratadine 10 mg.
Details
| Lead sponsor | Universidade do Sul de Santa Catarina |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 73 |
| Start date | 2013-08 |
| Completion | 2014-08 |
Conditions
- Allergic Rhinitis
Interventions
- Bilastine
- Loratadine
Primary outcomes
- Quality of life in patients with allergic rhinitis — 10 days
Application of the modified Rhinoconjunctivitis Quality of Life Questionnaire (RQLQm)